CRM646-A, a Fungal Metabolite, Induces Nucleus Condensation by Increasing Ca2+ Levels in Rat 3Y1 Fibroblast Cells
Author(s) -
Yukihiro Asami,
SunOk Kim,
JunPil Jang,
SungKyun Ko,
Bo Yeon Kim,
Hiroyuki Osada,
JaeHyuk Jang,
Jong Seog Ahn
Publication year - 2020
Publication title -
journal of microbiology and biotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.601
H-Index - 64
eISSN - 1738-8872
pISSN - 1017-7825
DOI - 10.4014/jmb.1908.08043
Subject(s) - fibroblast , metabolite , nucleus , chemistry , intracellular , protein kinase inhibitor , protein kinase a , telomerase , in vitro , microbiology and biotechnology , biochemistry , kinase , biology , gene
We previously identified a new heparinase inhibitor fungal metabolite, named CRM646-A, which showed inhibition of heparinase and telomerase activities in an in vitro enzyme assay and antimetastatic activity in a cell-based assay. In this study, we elucidated the mechanism by which CRM646-A rapidly induced nucleus condensation, plasma membrane disruption and morphological changes by increasing intracellular Ca 2+ levels. Furthermore, PD98059, a mitogen-activated protein kinase (MEK) inhibitor, inhibited CRM646-A-induced nucleus condensation through ERK1/2 activation in rat 3Y1 fibroblast cells. We identified CRM646-A as a Ca 2+ ionophore-like agent with a distinctly different chemical structure from that of previously reported Ca 2+ ionophores. These results indicate that CRM646-A has the potential to be used as a new and effective antimetastatic drug.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom